City Therapeutics
Drug Discovery

City Therapeutics: Funding & valuation

Funds reporting to the SEC (5) valued their City Therapeutics stock at $29.8M as of Jul 2026.

Data updated Nov 22, 2026 · Back to the company report

Money

Funds reporting to the SEC (5) valued their City Therapeutics stock at $29.8M as of Jul 2026.

Fund markswhat funds reporting to the SEC say their stakes are worth
Price a share in fund marks, by quarter
Jul 2026median of 1 marks · sec.gov ↗$14.60
May 2026median of 7 marks · sec.gov ↗$14.62
Feb 2026median of 3 marks · sec.gov ↗$10.32
Nov 2025median of 3 marks · sec.gov ↗$10.32
Aug 2025median of 3 marks · sec.gov ↗$9.45
Marks by fund: shares held, the price a share, the change since the last quarterPremiumUnlockor this company alone for 30 days · 50 credits
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".